Dishman Carbogen Amcis Limited provides contract research and manufacturing services for the pharmaceutical and healthcare industries worldwide. The company operates through Contract Research and Manufacturing Services and Marketable Molecules segments. It offers cholesterol and vitamin D analogs; generic active pharmaceutical ingredients for diagnostics, ophthalmic treatments, laxatives, organophosphate antidotes; ammonium, phosphonium; quats, phosphoranes, and wittig reagents; cholesterol and lanolin-related products; sterile injectables; and softgel formulations, as well as hand and body wash, sanitisers, and antiseptics. The company was founded in 1983 and is headquartered in Ahmedabad, India. Dishman Carbogen Amcis Limited is a subsidiary of Adimans Technologies LLP.
Metrics to compare | DSHM | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipDSHMPeersSector | |
---|---|---|---|---|
P/E Ratio | 44.2x | 23.4x | −0.7x | |
PEG Ratio | 0.31 | 0.06 | 0.00 | |
Price/Book | 0.8x | 3.7x | 2.6x | |
Price / LTM Sales | 1.6x | 4.1x | 3.4x | |
Upside (Analyst Target) | - | 10.5% | 38.0% | |
Fair Value Upside | Unlock | −6.4% | 5.3% | Unlock |